EP Patent

EP0344603B1 — Pharmaceutical composition of dihydropyridine compound

Assigned to Zeria Pharmaceutical Co Ltd · Expires 1991-10-23 · 35y expired

What this patent protects

Patent listed against pexidartinib-hydrochloride.

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: EP0344603B1
Jurisdiction: EP
Classification: —
Expires: 1991-10-23
Drug substance claim: No
Drug product claim: No
Assignee: Zeria Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.